Amedisys Announces Third Quarter Earnings Release and Conference Call Date
October 16 2018 - 12:00PM
Amedisys, Inc. (NASDAQ: "AMED"), announced today that it will
report results for the third quarter ended September 30, 2018 after
the market closes on October 29, 2018. The Company will host
an investor conference call to discuss these results at 11:00 a.m.
ET on October 30, 2018.
To participate on the conference call, please call a few minutes
before 11:00 a.m. ET to either (877) 524-8416 (Toll-Free) or (412)
902-1028 (Toll). A replay of the conference call will be
available through November 30, 2018. The replay dial-in
number is (877) 660-6853 (Toll-Free) or (201) 612-7415 (Toll) and
reference conference ID #13684177.
A live webcast of the call will be accessible
through our website on our Investor Relations section at the
following web address: http://investors.amedisys.com.
About Amedisys:Amedisys, Inc. is a leading
healthcare at home Company delivering personalized home health,
hospice and personal care. Amedisys is focused on delivering the
care that is best for our patients, whether that is home-based
personal care; recovery and rehabilitation after an operation or
injury; care focused on empowering them to manage a chronic
disease; or hospice care at the end of life. More than 3,000
hospitals and 59,000 physicians nationwide have chosen Amedisys as
a partner in post-acute care. Founded in 1982, headquartered in
Baton Rouge, LA with an executive office in Nashville, TN, Amedisys
is a publicly held company. With 18,400 employees in 421 care
centers in 34 states and the District of Columbia, Amedisys is
dedicated to delivering the highest quality of care to the
doorsteps of more than 369,000 patients and clients in need every
year. For more information about the Company, please visit:
www.amedisys.com.
We use our company website as a channel of
distribution for important company information. Important
information, including press releases, investor presentations and
financial information regarding the Company is routinely posted on
and accessible on the "Investor Relations" subpage of our website,
which is accessible by clicking on the tab labeled "Investors" on
our website home page. Visitors to our website can also register to
receive automated e-mail and other notifications alerting them to
when new information is made available on the Investor Relations
subpage of our website. In addition, we make available on the
Investor Relations subpage of our website (under the link "SEC
filings") free of charge our annual reports on Form 10-K, quarterly
reports on Form 10-Q, current reports on Form 8-K, ownership
reports on Forms 3, 4 and 5 and any amendments to those reports as
soon as practicable after we electronically file such reports with
the SEC. Further, copies of our Certificate of Incorporation and
Bylaws, our Code of Ethical Business Conduct, our Corporate
Governance Guidelines and the charters for the Audit, Compensation,
Quality of Care, Compliance and Ethics and Nominating and Corporate
Governance Committees of our Board are also available on the
Investor Relations subpage of our website (under the link
"Governance").
Contact:
Amedisys,
Inc.
Investor
Relations
855-259-2046
IR@amedisys.com
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2023 to Apr 2024